chrX-72130205-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The ENST00000609883.3(RTL5):​c.1336G>A​(p.Glu446Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,208,184 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.0000046 ( 0 hom. 1 hem. )

Consequence

RTL5
ENST00000609883.3 missense

Scores

1
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.625

Publications

0 publications found
Variant links:
Genes affected
RTL5 (HGNC:29430): (retrotransposon Gag like 5)
NHSL2 (HGNC:33737): (NHS like 2) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.043926507).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSL2NM_001013627.3 linkc.281-1874C>T intron_variant Intron 1 of 7 ENST00000633930.2 NP_001013649.2 Q5HYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTL5ENST00000609883.3 linkc.1336G>A p.Glu446Lys missense_variant Exon 1 of 1 6 ENSP00000476792.1 Q5HYW3
NHSL2ENST00000633930.2 linkc.281-1874C>T intron_variant Intron 1 of 7 5 NM_001013627.3 ENSP00000488668.1 Q5HYW2-1

Frequencies

GnomAD3 genomes
AF:
0.0000362
AC:
4
AN:
110487
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000383
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000111
AC:
2
AN:
180911
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000732
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000455
AC:
5
AN:
1097697
Hom.:
0
Cov.:
34
AF XY:
0.00000275
AC XY:
1
AN XY:
363135
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26399
American (AMR)
AF:
0.0000568
AC:
2
AN:
35184
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19347
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54070
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40505
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.00000356
AC:
3
AN:
841789
Other (OTH)
AF:
0.00
AC:
0
AN:
46063
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000362
AC:
4
AN:
110487
Hom.:
0
Cov.:
22
AF XY:
0.0000306
AC XY:
1
AN XY:
32701
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30266
American (AMR)
AF:
0.000383
AC:
4
AN:
10456
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2632
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3496
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2513
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5886
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52824
Other (OTH)
AF:
0.00
AC:
0
AN:
1492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000642
ExAC
AF:
0.00000825
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 23, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1336G>A (p.E446K) alteration is located in exon 1 (coding exon 1) of the RGAG4 gene. This alteration results from a G to A substitution at nucleotide position 1336, causing the glutamic acid (E) at amino acid position 446 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
10
DANN
Benign
0.89
DEOGEN2
Benign
0.00093
T
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.55
T
M_CAP
Benign
0.0020
T
MetaRNN
Benign
0.044
T
MetaSVM
Benign
-0.96
T
PhyloP100
0.63
PrimateAI
Benign
0.33
T
Sift4G
Uncertain
0.048
D
Polyphen
0.29
B
Vest4
0.14
MutPred
0.16
Gain of ubiquitination at E446 (P = 0.001);
MVP
0.014
ClinPred
0.042
T
GERP RS
0.046
Varity_R
0.058
gMVP
0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs777354507; hg19: chrX-71350055; API